Program Overview
Program Overview
| 10th June |
11th June |
12th June |
| Morning - 9:00 AM CEST | Morning - 9:00 AM CEST | Morning - 9:00 AM CEST |
Session 4. Cancer Survivorship and Quality of Life Session 1. Cancer Stem Cells |
Session 7. Novel Methods and Technologies for Research and Treatment |
Flash Poster Session Session 5. Causes, Diagnosis and Treatment of Cancer |
| Afternoon - 14:00 PM CEST | Afternoon - 14:00 PM CEST | Afternoon - 14:00 PM CEST |
Session 3. Drug Resistance and Anti-cancer Drug Development and Screening |
Session 7. Novel Methods and Technologies for Research and Treatment Session 2. Tumor Heterogeneity |
Session 5. Causes, Diagnosis and Treatment of Cancer |
IECC 2026 Program (Day 1)
10th June - Morning
IECC 2026
Session 4. Cancer Survivorship and Quality of Life
Date: 10th June 2026 (Wednesday)
Time: 09:00 (CEST, Basel) | 03:00 (EDT, New York) | 15:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 9:00-9:05 | Prof. Dr. Masaharu Seno Conference Chair |
Opening Remark from Conference Chair |
| 9:05-9:10 | Prof. Dr. Sebastiano Mercadante Session Chair |
Welcome from the Session Chair |
| 9:10-9:30 | Prof. Dr. Kwok-Leung Cheung Invited Speaker |
Quality of life and psychosocial wellbeing in older women with primary breast cancer |
| 9:30-9:50 | Prof. Dr. Ahmed Elsayem Invited Speaker |
When less is Actually more, Goals of Care for Patients with Advanced Cancer |
| 9:50-10:05 | Laia Barrachina-Bonet Selected Speaker |
The role of the European Cancer Information System on pancreatic cancer surveillance |
| 10:05-10:20 | Ruichen Han Selected Speaker |
Decision-making patterns of adjuvant endocrine therapy among women with breast cancer: A qualitative study |
| 10:20-10:35 | Elsa Vitale Selected Speaker |
Influence of Heath Literacy on Quality of Life in oncology patients |
| 10:35-10:50 | Qiang Hu Selected Speaker |
The Impact of Mobile Health on the Quality of Life of Cancer Patients: An interventional study |
| 10:50-11:05 | Alexandru Roșu Selected Speaker |
Clinical outcomes of Sacituzumab Govitecan in metastatic breast cancer: evidence of survival and quality of life from a systematic review and meta analysis |
10th June - Morning
IECC 2026
Session 1. Cancer Stem Cells
Date: 10th June 2026 (Wednesday)
Time: 11:05 (CEST, Basel) | 5:05 (EDT, New York) | 17:05 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 11:05-11:10 | Prof. Dr. Masaharu Seno Prof. Dr. Angeliki Magklara Session Chairs |
Welcome from the Session Chair |
| 11:10-11:25 | Junyi Lin Selected Speaker |
Biomimetic Homotypic Nanoparticles Co-delivering Gemcitabine and IKKβ Inhibitor Reverse Gemcitabine induced Stemness for Enhanced Pancreatic Cancer Therapy |
| 11:25-11:40 | Gaia Giannitti Selected Speaker |
Dissecting the contribution of CD36 to extracellular vesicle–driven metabolic crosstalk between melanoma cells and adipocytes |
10th June - Afternoon
IECC 2026
Session 3. Drug Resistance and Anti-cancer Drug Development and Screening
Date: 10th June 2026 (Wednesday)
Time: 14:00 (CEST, Basel) | 8:00 (EDT, New York) | 20:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 14:00-14:05 | Dr. Farrukh Aqil Session Chair |
Welcome from the Session Chair |
| 14:05-14:20 | Alaa Aboushanab Selected Speaker |
Synergistic Chemo-Immunomodulation via Nanocarrier Co-Delivery of Doxorubicin and Pexidartinib |
| 14:20-14:35 | Mariana Sousa Selected Speaker |
Functional reactivation of p53 as a promising therapeutic strategy in the treatment of ovarian cancer |
| 14:35-14:50 |
Inês Mota
|
Combination of BBIT20 and Immunotherapy Enhances Antitumor Activity in Pancreatic Cancer |
| 14:50-15:05 | Ana Catarina Matos Selected Speaker |
Restoring therapeutic vulnerability in Multidrug-Resistant Ovarian Cancer with a first-in-class disruptor of the BRCA1–BARD1 interaction |
| 15:05-15:20 | SYLWIA AMMOUN Selected Speaker |
Cellular Prion Protein (PrPC) as a Therapeutic Target in Meningioma and Schwannoma Development and Multidrug Resistance |
| 15:20-15:35 |
Wioletta Rozpędek-Kamińska |
Selective PERK inhibition as a strategy to overcome hypoxia-induced survival in colorectal cancer cells |
| 15:35-15:50 |
Alexander A. Shtil |
Electrochemical Reduction of Copper (II) As a Potent and Versatile Approach for Tumor Cell Eradication |
| 15:50-16:05 |
Martyna Natalia Muskała |
Induction of apoptosis by extracts from transformed hairy roots of Plectranthus venteri in an in vitro cancer model |
| 16:05-16:20 |
farnaz mohammadi |
Targeting EPS8 by CRISPR/Cas9 Genome Editing Reduces Gemcitabine Resistance in Pancreatic Cancer Cells |
| 16:20-16:40 |
Prof. Dr. Axel H. Schönthal |
Development of Novel Drug Delivery Pathways Enabled by Perillyl Alcohol (NEO100), a Monoterpene with Multifaceted Biomedical Applications |
IECC 2026 Program (Day 2)
11th June - Morning
IECC 2026
Session 7. Novel Methods and Technologies for Research and Treatment
Date: 11th June 2026 (Thursday)
Time: 09:00 (CEST, Basel) | 03:00 (EDT, New York) | 15:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 9:00-9:05 | Prof. Dr. Guomin Li Session Chair |
Welcome from the Session Chair |
| 9:05-9:20 | Olga Tselousova Selected Speaker |
CIRCULATING TUMOR DNA AS A BIOMARKER OF GENOMIC INSTABILITY AND CLONAL EVOLUTION IN BREAST CANCER |
| 9:20-9:35 | Ekaterina Lindunen Selected Speaker |
Bioinformatic Identification of ACTN4 as a Candidate Master Regulator of Local Invasion in Glioblastoma |
| 9:35-9:50 | Yuzhe Wang Selected Speaker |
A Novel CAM-Based Dual-Reporter Imaging Platform to Study Secretome-Driven Vascular Remodeling in Sarcoma |
| 9:50-10:05 | Michael Laurence Langsen Selected Speaker |
Validation and Clinical Translation of Non-Invasive Imaging Biomarkers for the Classification of Gliomas |
| 10:05-10:20 | Anna Shorina Selected Speaker |
Machine Learning-Based Association of Copy Number Alterations in a Mechanobiological Gene Panel with Metastatic Status Across Cancer Types |
| 10:20-10:35 | Olga Kamaeva Selected Speaker |
Investigation of the Protein Corona on Polyvinyl Alcohol-Stabilized Polymeric Nanoparticles |
| 10:35-10:50 | Elizaveta Kontareva Selected Speaker |
High-nitrogen artificial gas mixture-induced hypoxia decreases nanoparticle uptake in breast tumor cells with varying malignancy |
| 10:50-11:05 | Nikhil Gudivada Selected Speaker |
An analysis of RCTs using PARP inhibitors in the treatment of breast cancer |
| 11:05-11:20 | Maryem Mahfoud Selected Speaker |
Exploration of genes identified in antitumor resistance in triple-negative breast |
| 11:20-11:35 | Omar Hamad Selected Speaker |
Digital Pathology Approach to Mapping Collagen VI Tumor Spatial Arrangement in COVID-19 Tissue Slides Using ImageJ |
11th June - Morning
IECC 2026
Session 7. Novel Methods and Technologies for Research and Treatment
Date: 11th June 2026 (Thursday)
Time: 14:00 (CEST, Basel) | 08:00 (EDT, New York) | 20:00 (CST Asia, Beijing)
|
IECC 2026
Session 2. Tumor Heterogeneity
Date: 11th June 2026 (Thursday)
Time: 15:30 (CEST, Basel) | 9:30 (EDT, New York) | 21:30 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 15:30-15:35 | Prof. Dr. Henry H. Heng Session Chair |
Welcome from the Session Chair |
| 15:35-16:05 | Prof. Dr. Henry H. Heng Keynote Speaker |
Cancer as a Supersystem: Chromosomal Instability Drives Multiscale Heterogeneity Through Two-Phased Evolution |
| 16:05-16:35 | Prof. Dr. Jinsong Liu Keynote Speaker |
Polyploid Giant Cancer Cells as a Window into Tumor Heterogeneity |
| 16:35-16:50 | Paula De Juan-Maciá Selected Speaker |
The hypertrophic adipocyte niche fuels metabolic plasticity and invasive signaling in colorectal cancer |
| 16:50-17:05 | Fei Yang Selected Speaker |
Intratumoral Metabolic Heterogeneity Predicts Treatment Response in High-Risk Hodgkin Lymphoma: Evidence from the AHOD0831 Trial |
| 17:05-17:20 | Elena Filippova Selected Speaker |
SNHG6-centered RNA regulatory network links epithelial plasticity and apoptosis signaling in breast cancer |
| 17:20-17:35 | Fabrizio Fontana Selected Speaker |
Unraveling the role of extracellular vesicle-mediated interleukin-8 signaling in melanoma invasion |
IECC 2026 Program (Day 3)
12th June - Morning
IECC 2026
Flash Poster Session
Date: 12th June 2026 (Friday)
Time: 09:00 (CEST, Basel) | 03:00 (EDT, New York) | 15:00 (CST Asia, Beijing)
|
Session
|
Poster Presenter
|
Title
|
|
Session 1
|
||
| 9:00-9:05 | Olga Pershina Selected Speaker |
Age-related features of cancer stem cell and T-cell response to therapy in a lung cancer model in aged mice |
| Session 2 | ||
| 9:05-9:10 | Alexey M. Burdennyy Selected Speaker |
Tumor-associated miR-124 and miR-137 in post-transcriptional regulation of ovarian cancer |
| 9:10-9:15 | Meryem Aarab Selected Speaker |
Phenotypic Heterogeneity of Circulating Tumor Cells in Lung Cancer Revealed by Immunocytochemical Profiling |
| 9:15-9:20 | Maria Francesca Fiorita Selected Speaker |
Adipocyte-Derived Conditioned Medium Influences the Malignant Phenotype of Human Breast Cancer-Associated Fibroblasts |
| Session 3 | ||
| 9:20-9:25 | Mariarosa Fava Selected Speaker |
Lamotrigine Inhibits Breast Cancer Progression Through FoxO3a/TXNIP axis |
| 9:25-9:30 | Yueyang Zhang Selected Speaker |
Evaluation of Lobaplatin Chemosensitivity and Mechanistic Insights Using a 3D Bioprinted Primary Colorectal Cancer Model |
| 9:30-9:35 | Ye Yuan Selected Speaker |
Vimentin facilitates ubiquitination and degradation of NCOA4 to promote resistance to olaparib-induced ferroptosis in glioblastoma |
| 9:35-9:40 | Souandaou ATHOUMANI ALI Selected Speaker |
An RNA Sequencing approach for the identification of anticancer effects of Docetaxel in cervical cancer |
| Session 4 | ||
| 9:40-9:45 | Ioannis Adamopoulos Selected Speaker |
Survival impact of surgery and radiotherapy in malignant phyllodes tumors: Meta-Analysis of cohort studies |
| 9:45-9:50 | Marzia Sichetti Selected Speaker |
MIND–BODY INTERVENTION FOR SYMPTOM MANAGEMENT IN BREAST CANCER SURVIVORSHIP: A FEASIBILITY QIGONG PILOT STUDY |
| Session 5 | ||
| 9:50-9:55 | Linda Manna Selected Speaker |
Serum from Subjects with High Body Mass Index Modulates Multiple Myeloma Cell Phenotype |
| 9:55-10:00 | Ionela Codruta Bubuianu Selected Speaker |
Decoding Therapy-induced Senescence EVs: Proteomic and miRNomic Clues to NSCLC Chemoresistance |
| 10:00-10:05 | Erina Iwabuchi Selected Speaker |
Significance of HER2-related factor in HER2-low breast cancer |
| 10:05-10:10 | Lisa Elm Selected Speaker |
Distinct YAP-TEAD signaling states revealed by integrated mRNA and protein analysis in thymic epithelial neoplasms |
| Session 7 | ||
| 10:10-10:15 | Sofia Kleimenova Selected Speaker |
Development of novel drug delivery systems based on extracellular vesicles and cell membranes for cancer therapy |
| 10:15-10:20 | Michaila Akathi Pantelaiou Selected Speaker |
Smart nanocarriers encapsulating chemotherapeutic agents |
| 10:20-10:25 | Daria Prilutskaya Selected Speaker |
Extracellular vesicles as a targeted drug delivery platform for cancer treatment |
| 10:25-10:30 | Anastasia Dubrovina Selected Speaker |
Development Omnipose Neural Network-Based Analytical Module for Morphometric Analysis of Metastatic Cancer Cells |
12th June - Morning
IECC 2026
Session 5. Causes, Diagnosis and Treatment of Cancer
Date: 12th June 2026 (Friday)
Time: 10:30 (CEST, Basel) | 04:30 (EDT, New York) | 16:30 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 10:30-10:45 | Daniele Viavattene Selected Speaker |
Guilty by association: calcium-mediated apoptosis regulated at the ER by a newly discovered mTOR-STAT3 pathway |
| 10:45-11:00 | Wenyu Xue Selected Speaker |
Integrated Clinical and Functional Analysis Identifies miR-16-1-3p as an Active Passenger Strand Associated with Osteosarcoma Progression and Chemoresistance |
| 11:00-11:15 | Nemany A.N. Hanafy Selected Speaker |
Hyaluronic acid-functionalized CaCO₃ crystals as novel polyelectrolyte multilayer reservoirs for CPT-RB (Chemotherapy and Photodynamic therapy) targeting multiple myeloma |
| 11:15-11:30 | Ladislav Görög Selected Speaker |
Ratiometric TGF-β–MMP Biomarkers Capture Pathway Imbalance and Stratify Colorectal Cancer Progression |
| 11:30-11:45 | Imane SAIF Selected Speaker |
Evaluation of the epigenetic signatures of BRCA1 and TP53 as tools for metastatic prognosis: Translational study on a cohort of Moroccan women |
12th June - Afternoon
IECC 2026
Session 5. Causes, Diagnosis and Treatment of Cancer
Date: 12th June 2026 (Friday)
Time: 14:00 (CEST, Basel) | 08:00 (EDT, New York) | 20:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 14:00-14:05 | Prof. Nicola Amodio Session Chair |
Welcome from the Session Chair |
| 14:05-14:25 | Dr. Enrica Antonia Martino Invited Speaker |
Diagnosis and treatment of Multiple Myeloma |
| 14:25-14:40 | Ilenia Valentino Selected Speaker |
MARCH5-Driven MFN2 Degradation Sustains Mitochondrial Fission and Drug Resistance in Multiple Myeloma |
| 14:40-14:55 | Valeria Abril Pelayo-Ramírez Selected Speaker |
In Silico Transcriptomic Identification of Recurrent Transmembrane Receptors Across 12 Major Cancers for Targeted Non-Viral Gene Therapy |
| 14:55-15:10 |
Oloche Celestine Eije |
Brain Cancer Gene Expression Analysis for Subtype Classification and Biomarker Discovery Using Machine Learning |
| 15:10-15:25 | Wei-Hsiung Yang Selected Speaker |
Transcription factor NR5A1 enhances wild-type p53 transactivation |
| 15:25-15:40 | Francesca Gualtieri Selected Speaker |
Heparan Sulfate-Mediated Mechanotransduction Promotes EMT and Aggressiveness in Ovarian Cancer |
| 15:40-15:55 | Kaoutar ANOUAR TADLAOUI Selected Speaker |
miR-200c and PRR11: A Diagnostic Duo in HPV-Driven Cervical Cancer—Unraveling Their Inverse Regulation for Early Detection |
| 15:55-16:10 | Elena Marusich Selected Speaker |
Iron Oxide Nanoparticles as Potential Agents for Combined Radiotherapy |
| 16:10-16:25 | Xiaoke Wang Selected Speaker |
Stem Cell Exhaustion Defines an Immunogenic Niche and a Circulating Biomarker for Nasopharyngeal Carcinoma |
| 16:25-16:40 | Xiaohong Li Selected Speaker |
Pralsetinib for RET Fusion-Positive Advanced Ascending Colon Cancer with Liver Metastasis: A Case Report and Literature Review |